Sponsored by:
Cisco (CSCO)
Pepsico (PEP)
Walt Disney (DIS)
Netflix (NFLX)
Focus Stocks
Featured Stories
Tractor Supply Declares Quarterly Dividend
Sonoco Reports Earnings
Sealed Air Earnings Report
IMAX Closing in to Resistance
Upside Looming for Dow?
Medtronic CEO William Hawkins to Speak at Morgan Stanley Global Healthcare Conference
Published on Friday, 03 September 2010 13:04 Written by TradersHuddle Staff
MINNEAPOLIS-( Business Wire )-Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference on Monday, September 13, 2010, in New York City.
William Hawkins, chairman and chief executive officer of Medtronic, is scheduled to speak to attendees of the conference at 10:55 a.m. EDT (9:55 a.m. CDT). Hawkins is scheduled to provide remarks highlighting Medtronic’s plan to deliver sustainable top and bottom line growth. A live audio webcast of the presentation will be available and can be accessed by clicking on the Investors link on the Medtronic home page at http://www.medtronic.com/.
About Medtronic
Medtronic, Inc. (www.medtronic.com),
headquartered in Minneapolis, is the global leader in medical technology
– alleviating pain, restoring health, and extending life for millions of
people around the world.
Related Articles
- Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
- Approaching Resistance - Medtronic
- Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting
- Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve® System Using Direct Aortic Approach
- Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices
- Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami Instruments
- Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial
- First Patient Enrolled in Medtronic-Supported Head-to-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation
- Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
- Medtronic Endurant® II AAA Stent Graft System Launches Internationally with CE Mark
Related Partner Headlines
- Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting - Benzinga
- Medtronic Says Data from Corevalue Demonstrates Positive Outcomes - Benzinga
- Medtronic Stock To Go Ex-dividend Tomorrow (MDT) - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Care Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Care Winner - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. Stock Upgraded (MDT) - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Winner - TheStreet.com
JIM CRAMER wants to work for YOU. JIM does the research -- YOU get email alerts each time he trades. JIM provides access to his actual portfolio -- YOU can use it to guide your portfolio strategy.
Try Jim's Action Alerts PLUS for FREE!
TradersHuddle Search
| Sponsored By:
|
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
